AzTrials
AzTrials

Intimate Partner Violence (IPV)RISENCT06906302

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

A study testing RISE and Advocacy-based ECAU in people with Intimate Partner Violence (IPV), run by Boston University at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE)… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intimate Partner Violence (IPV)
What is being tested?
RISE and Advocacy-based ECAU
Could I receive a placebo?
No, everyone receives an active treatment
How many people
172 participants
Where
3 sitesUnited States
Study dates
15 Sep 2025to Jan 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
  • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
  • be able to provide informed consent including permission to have intervention sessions recorded

Who cannot join

  • severe cognitive impairment,
  • suicide or homicide intent with a specific plan
  • untreated or unstable symptoms of mania or psychosis

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Katherine M Iverson, PhD contact

857-364-2066

Katherine.Iverson@va.gov

Julianne Brady contact

Julianne.Brady@va.gov

United States3 sites, 3 recruiting
  • VA Boston Healthcare System

    Boston, Massachusetts, 02130

    Katherine M Iverson, PhD

    Recruiting
  • VA Minneapolis Healthcare System

    Minneapolis, Minnesota, 55417

    Princess Ackland, PhD

    Recruiting
  • VA Philadelphia Healthcare System

    Philadelphia, Pennsylvania, 19104

    Melissa Dichter, PhD

    Recruiting

Other trials in United States

About this study

Official title: Recovering From IPV Through Strengths and Empowerment (RISE) Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.

Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

Being tested
RISE, Advocacy-based ECAU
Keywords
RISE, Enhanced Care as Usual (ECAU), Healthcare patients, Self-efficacy, Depression, Post-Traumatic Stress Disorders (PTSD)
Medical subject headings
Depression, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RISEBehavioural

    RISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total).

  • Advocacy-based ECAUBehavioural

    Advocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals.

Study groups in NCT06906302
Study groupRoleWhat they receive
RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)ExperimentalParticipants randomized to the RISE arm will have 1 or more RISE sessions.
Receives: Behavioral: RISE
Advocacy-based ECAU (Enhanced Care as Usual)Active comparatorParticipants randomized to this arm will have a single Advocacy-based ECAU session
Receives: Behavioral: Advocacy-based ECAU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-efficacy

    Self-efficacy will be assessed with the General Self-Efficacy Scale (GSES), a 10-item instrument with possible responses for each item from 1 to 4 where 1= Not at all true, 2= Hardly true, 3= Moderately true, and 4=Exactly true.Scores can range from 10 to 40 and higher scores indicate more self efficacy.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

Secondary outcomes (12)
  1. Depressive symptoms

    Depressive symptoms will be assessed with the Center for Epidemiologic Studies Depression Scale (CESD), a 20-item instrument with possible responses for each item from 0 to 3 where 0= Rarely or none of the time (less than 1 day), 1= Some or a little of the time (1-2 days), 2= Occasionally or a moderate amount of the time (3-4 days), and 3= Most or all of the time (5-7 days). Possible range of scores is 0 to 60, with the higher scores indicating more depressive symptoms.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  2. Post traumatic stress disorder (PTSD) symptoms

    PTSD symptoms will be assessed with the PTSD Checklist -DSM-5, a 20-item self-report measure of the DSM-5 symptoms of PTSD. A 5-point Likert scale is used for each item from 0 = "Not at all" to 4 = "Extremely". Total possible scores can range from 0 to 80 with higher scores indicating more PTSD symptoms.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  3. Alcohol use

    Alcohol use will be assessed with the Alcohol Use Disorders Identification Test-10 (AUDIT-10), a 10-item instrument with possible responses for each item from 0 to 4 for questions 1-8 and possible responses of 0, 2, and 4 for questions 9 and 10. Total possible scores can range from 0 to 40 with higher scores indicating greater alcohol use.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  4. Hopelessness

    Hopelessness will be assessed by the 20-item Beck Hopelessness Scale (BHS). The BHS is scored by adding up the responses to 20 true-false questions. The possible score range is 0-20, with higher scores indicating greater hopelessness.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  5. Self-reported quality of life

    Quality of life will be assessed by World Health Organization - Quality of Life, Brief WHOQOL-BREF instrument, a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100-scale with higher scores indicating a better quality of life.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  6. Valued living

    Valued living will be assessed with the Valued Living Questionnaire (VLQ) focusing on 10 valued domains of living which include (1) family, (2) marriage/couples, intimate relations, (3) parenting, (4) friendship, (5) work, (6) education, (7) recreation, (8) spirituality, (9) citizenship, and (10) physical self-care. Each domain is rated on a scale of 1-10, based on the level of importance to the respondent and the extent to which they have lived consistent with their values in the past week. A total score is calculated by multiplying the importance and consistency ratings for each domain, and then averaging those scores. Total scores range from 10 to 100 with higher scores indicating greater alignment with one's values.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  7. IPV

    Experiences of IPV from past or a current intimate partner will be measured using subscales of the Revised Conflict Tactics Scale (CTS-2). The physical aggression (12 items), psychological aggression (8 items), and sexual coercion (7 items) subscales include 27 items regarding the frequency of different IPV experiences (0=this has never happened, 1=1 time, 2=2 times, 3=3-5 times, 4=6-10 times, 5=11-20 times, and 6=20+ times). Items are summed for a total frequency score. Additionally, the number of different IPV behaviors experienced can be tallied to reflect a indicate the number of different IPV behaviors experienced. Higher scores reflect greater levels of IPV experience.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  8. Measure of Victim Empowerment Related to Safety

    Safety-related Empowerment will be measured with the Measure of Victim Empowerment Related to Safety (MOVERS), a 13- item measure that consists of three subscales: internal resources (6 items), expectations of support (4 items), and trade-offs (3 items), with response options on a scale from 1-5, with 1 being "never true" and 5 being "always true" for each internal resource and expectation of support subscale question. Responses options for the trade-off subscale are reverse scored with 1 = Always true and 5= Never true. Total possible scores can range from 13 to 65, with higher scores indicating higher levels of empowerment.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  9. Health care and social service use

    Items adapted from the National Survey of Veterans and prior studies examining health and social service use among individuals experiencing IPV, particularly in terms of VA and non-VHA psychosocial health services (e.g., mental health, housing, domestic violence agencies). The number and types of psychosocial treatment services will be examined.

    Measured: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months

  10. VHA health care use

    VHA health care use will be extracted from the electronic medical records. The types and number of services used, particularly psychosocial health services, will be examined.

    Measured: 12 months before baseline, 12 months after baseline

  11. Treatment satisfaction

    Treatment satisfaction will be assessed using the 8-item Client Satisfaction Questionnaire-8 (CSQ-8). Possible scores range from 8 to 32, with higher values indicating higher treatment satisfaction.

    Measured: 3 months

  12. Perceived Benefits/Harms

    Perceived benefits/harms from participating in the interventions will be measured using 6 items adapted from prior studies. Possible responses on a Likert scale range from 1= strongly disagree to 5 = strongly agree, with item 4 reverse scored. Individual item scores and total scores will be examined.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2025
  2. Study start15 Sep 2025
  3. Primary completionJan 2030 (estimated)
  4. Study completionJan 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
172 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06906302
Sponsor's protocol ID
H-45215
Other IDs
BPS-2023C2-33320
Acronym
RISE
Status last verified
Sep 2026
First submitted
1 Apr 2025
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing RISE and Advocacy-based ECAU in people with Intimate Partner Violence (IPV), run by Boston University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Katherine M Iverson, PhD (857-364-2066, Katherine.Iverson@va.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-efficacy (time frame: Baseline, 3 months, 6 months. 9 months, 12 months, 15 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in